News & Updates

The 48-month analysis of the global phase III Clarity AD study shows that lecanemab continues to deliver benefit and delay progression in early Alzheimer's disease (AD).

Patients with rheumatoid arthritis (RA) who are living in areas with disadvantageous socioeconomic status (SES) appear to have higher disease activity, disability, and poorer quality of life (QOL), as shown in a study in Australia.

A study presented at ESMO Breast Cancer 2026 shows that a custom-made external breast prosthesis has a slight advantage over a standard prosthesis among breast cancer patients who have undergone mastectomy.